Quick Answer
Galmed Pharmaceuticals Ltd. reported Long-Term Debt of $0.00 for fiscal year 2017.
Galmed Pharmaceuticals Ltd. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2017 | $0.00 | -100.0% |
| 2016 | $796.0K | +349.7% |
| 2015 | $177.0K | -55.8% |
| 2014 | $400.0K | -6.5% |
| 2013 | $428.0K | — |
- Galmed Pharmaceuticals Ltd. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2013–2017 period, Galmed Pharmaceuticals Ltd.’s long-term debt has declined by 100.0% (from $428.0 thousand to $0.00).
- The most recent figure is from Galmed Pharmaceuticals Ltd.’s fiscal year 2017 report (Form 20-F), filed with the SEC on March 13, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: